bims-rebome Biomed News
on Rehabilitation of bone metastases
Issue of 2025–12–14
three papers selected by
Alberto Selvanetti, Azienda Ospedaliera San Giovanni Addolorata



  1. Br J Anaesth. 2025 Dec 08. pii: S0007-0912(25)00794-9. [Epub ahead of print]
      
    Keywords:  long bone fractures; metastatic bone disease; orthopaedic oncology; perioperative guidelines; regional anaesthesia
    DOI:  https://doi.org/10.1016/j.bja.2025.10.050
  2. Chirurgie (Heidelb). 2025 Dec 08.
      Bone metastases are the most common malignant bone tumors and are often the first clinical sign of a malignant disease. Although the occurrence of bone metastases in a malignant disease usually means a palliative situation for patients, adequate treatment of the metastases can greatly improve the patient's prognosis and ensure that the quality of life is maintained. In addition to oncological and radiotherapeutic treatment options, there are many surgical treatment options available. For this reason, metastasis surgery is the most common oncological operation in musculoskeletal surgery. The indications for metastasis surgery should always be assessed in an interdisciplinary setting, taking the patient's life expectancy, physical limitations and wishes into account. This review article summarizes the various surgical treatment options for bone metastases depending on the region of the body.
    Keywords:  Metastasis surgery; Oncological surgery; Osseous metastases; Palliative surgery; Pathological fracture
    DOI:  https://doi.org/10.1007/s00104-025-02421-w
  3. Int J Surg. 2025 Dec 11.
       BACKGROUND: Spinal metastases frequently cause debilitating symptoms and require complex surgical management, with postoperative intensive care unit (ICU) admissions representing a major concern. This multicenter study aimed to develop and validate machine learning (ML) models to predict 30-day unplanned ICU admission following metastatic spinal tumor surgery.
    METHODS: A total of 642 patients with metastatic spinal disease were enrolled, and 525 from two major institutions were randomly split into derivation (80%) and internal validation (20%) cohorts. External validation was performed using an independent cohort (n = 117) from a third medical institution. Six ML algorithms were trained on 11 clinically significant features selected after multicollinearity analysis.
    RESULTS: In the model development cohort, significant differences were observed between ICU (n = 101, 19.2%) and non-ICU groups, with ICU patients demonstrating higher comorbidity burdens, elevated inflammatory markers, and impaired renal function. Among six machine learning models evaluated, the KNN algorithm demonstrated superior predictive performance with the highest discriminative power (Area Under the Curve [AUC]: 0.884), accuracy (82.1%), recall (96.4%), and favorable calibration (Brier score: 0.149). The ANN also performed well, achieving the second-highest AUC (0.847), precision (0.808), and F1 score (0.778), as well as a competitive log loss (0.491). The composite scoring system confirmed KNN and ANN as top performers (total scores: 42 each), but, in the external validation cohort, the KNN model demonstrated significantly superior discriminative ability compared to the ANN model, with an AUC of 0.834 (95% CI: 0.773-0.894) versus 0.741 (95% CI: 0.665-0.816) respectively (Delong test, P<0.001).
    CONCLUSION: This study presents validated ML models specifically designed for ICU admission prediction following spinal metastasis surgery, with the KNN model performing satisfactory performance and demonstrating strong potential for clinical implementation.
    Keywords:  K-nearest neighbors; intensive care unit; machine learning; metastatic spinal tumors; postoperative ICU admission; predictive modeling
    DOI:  https://doi.org/10.1097/JS9.0000000000004416